VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,220,000,000 | +42962.2% | 309,800 | -61.2% | 0.78% | -62.5% |
| Q4 2017 | $12,122,000 | +36.1% | 797,531 | +60.3% | 2.07% | +19.3% |
| Q3 2017 | $8,906,000 | -75.5% | 497,531 | -77.7% | 1.73% | -73.4% |
| Q2 2017 | $36,385,000 | +16.4% | 2,232,238 | 0.0% | 6.52% | +5.0% |
| Q1 2017 | $31,251,000 | -2.5% | 2,232,238 | +11.1% | 6.21% | -5.8% |
| Q4 2016 | $32,060,000 | -28.8% | 2,010,000 | -25.7% | 6.59% | -42.7% |
| Q3 2016 | $45,030,000 | +48.7% | 2,706,134 | +0.0% | 11.48% | +32.5% |
| Q2 2016 | $30,277,000 | +32.6% | 2,705,758 | -0.9% | 8.67% | +5.8% |
| Q1 2016 | $22,833,000 | +16.8% | 2,731,210 | +30.1% | 8.19% | -0.1% |
| Q4 2015 | $19,552,000 | +1.1% | 2,100,101 | +22.5% | 8.20% | +7.2% |
| Q3 2015 | $19,345,000 | +7.8% | 1,715,000 | +21.3% | 7.65% | +9.4% |
| Q2 2015 | $17,939,000 | +38.9% | 1,413,599 | +1.8% | 6.99% | +23.0% |
| Q1 2015 | $12,914,000 | – | 1,388,599 | – | 5.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |